Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-078122
Filing Date
2020-06-29
Accepted
2020-06-29 18:49:21
Documents
1
Period of Report
2020-06-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 tm2023597d3_form4.html 4  
1 FORM 4 tm2023597d3_form4.xml 4 3980
  Complete submission text file 0001104659-20-078122.txt   5446
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12 PINE STREET PHILADELPHIA PA 19106
Business Address
UPRICHARD DAVID C (Reporting) CIK: 0001239916 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50626 | Film No.: 20998712